The obtained results suggest that patients carrying pathogenic variants of WFS1 should be diagnosed and treated before any clinical symptoms such as diabetes and loss of vision occur as it could delay syndrome progression and therefore improve the quality of life and increase the number of healthy life years. Here, WFS1 is linked to diabetes mellitus.